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Context: Reduced testosterone levels have been implicated as a po-
tential causative factor in cognitive decline with older age. Men who
possess the apolipoprotein E (APOE) 4 allele have an increased risk
ofdevelopingAlzheimer’sdisease;however,nostudieshaveexamined
whether the influence of testosterone on cognition in healthy older
men may be modulated by this genetic predisposition.
Objective: The objective of the study was to investigate the associ-
ation between serum testosterone concentrations and cognitive per-
formance in healthy older men, taking into account APOE 4 status.
Design: This was a cross-sectional study conducted from 2003 to
2004.
Setting: The study population consisted of community-dwelling
males residing in Perth, Western Australia.
Participants: Healthy men over 55 yr, free of cognitive impairment
and dementia (n  45), were included in the study.
Main Outcome Measures: Participants had fasting early morning
bloodsamplesfortestosteroneandSHBGandwereassessedformood
as well as indices of general cognition, verbal and visual memory,
executive functioning, working memory, and attention.
Results: There was a significant interaction between calculated free
testosterone (FT) and APOE 4 on general cognition (P  0.01) and
executive functioning, working memory, and attention (P  0.01).
Higher levels of FT were associated with better general cognition in
non-4 carriers (P  0.01). By contrast, in 4 carriers higher FT levels
were associated with lower scores on tests of executive functioning,
working memory, and attention (P  0.02). In men at increased risk
forAlzheimer’sdisease,highertestosteronelevelswerenotassociated
with better cognitive function.
Conclusions:Cross-sectionalandprospectivestudiesoftestosterone
and cognition in older men should take into account APOE 4 status.
(J Clin Endocrinol Metab 91: 1168–1172, 2006)
L
OWER TESTOSTERONE concentrations have been as-
sociated with lower scores on tests of cognitive ability
(1, 2) and the subsequent development of Alzheimer’s dis-
ease (AD) (3). Testosterone deficiency modulates neuronal
processes capable of increasing the risk for AD (4), and ben-
eficial effects of testosterone supplementation have been re-
ported on specific parameters of cognition in older men (5,
6). The apolipoprotein E (APOE) 4 allele is thought to be the
major genetic risk factor for AD (7) and may independently
modulate normal age-related cognitive change (8). An asso-
ciation among low testosterone, APOE 4, and AD has been
reported (9), but it is not known whether testosterone and
APOE 4 interact to modulate cognition in men before the
development of AD or whether differential effects of testos-
terone on cognition exist that are influenced by the absence
or presence of 4. We investigated the association among
testosterone concentrations, genetic risk for AD, and cogni-
tive abilities in healthy older men.
Patients and Methods
Patients
Our institutional ethics committee approved this study and informed
consentwasobtainedfromparticipants.Community-dwellingmenover
55 yr of age with no history of cognitive impairment, dementia, or other
major medical illness were recruited. Exclusion criteria were hormone-
suppressive therapy, testosterone therapy, medications known to affect
bone metabolism within the past 3 months, significant prostate disease,
abnormal liver function, hypothyroidism, major sleep disturbance, con-
sumptionofalcoholgreaterthan21U/wk,psychiatricdisorders,stroke,
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1168head injuries, scores 80 or less on the Cambridge Cognitive Assessment-
revised (CAMCOG-R) (10) (identifying frank cognitive deficits), and 1.5
sd or greater below the mean for age on measures of verbal learning and
memory(identifyingmildcognitiveimpairment).Aftertheseexclusions
there were 45 healthy men studied.
Procedures
Information concerning: current medical problems, medications, life-
style factors, and years of formal education (cumulative years of pri-
mary, secondary, and tertiary education) were obtained, and blood
pressure and body mass index (kilograms per square meter) was mea-
sured. Blood samples were collected between 0830 and 1030 h after
overnight fasting. A standard breakfast (energy value 938 kJ) was pro-
vided before cognitive testing of constructs cited as relevant in the AD
literature (11) and parameters influenced by testosterone concentrations
(1, 2, 5, 6).
Biochemical assessments. Total testosterone concentrations were deter-
mined by coated tube RIA (Coat-A-Count, Diagnostic Products Corp.-
BioMediq, Doncaster, Australia) with coefficient of variation being 8.9%
at 2.5 nmol/liter and 8.5% at 14 nmol/liter. SHBG concentrations were
determined via chemiluminescent immunoassay on an Immulite 2000
analyzer (Diagnostic Products Corp.-BioMediq) with coefficient of vari-
ation of 6.8% at 5.1 nmol/liter and 9.3% at 82.5 nmol/liter. Free testos-
terone (FT), specifically the fraction not bound to either SHBG or albu-
min, was calculated using a previously validated method (12).
APOE genotyping. Peripheral blood leukocyte DNA was extracted and
APOE genotyping was performed as previously described (13).
Mood assessments. Depressive symptomatology was assessed via the
Geriatric Depression Scale (14). Current anxiety levels were assessed via
the State Anxiety Scale from the Spielberger State Trait Anxiety Inven-
tory (15).
Neuropsychological tests
The National Adult Reading Test (16) was administered to derive an
estimate of full-scale intelligence quotient (FSIQ) to control for differ-
ences in reading and estimated intellectual ability. The following tests
were administered to obtain the listed cognitive constructs:
1. General cognition. CAMCOG-R (10) total score was analyzed to obtain
an index of performance on orientation, memory, language, praxis,
attention, tactile perception, calculation, abstract thinking, and visual
perception tasks.
2. Immediate memory. Immediate recall for verbal information on Wech-
sler Memory Scale-Third Edition (WMS-III) (17) Wordlists and visual
information on the visual reproduction (VR) subtests was analyzed.
3. Delayed memory. Comprised delayed recall, recognition, and percent-
age retention of verbal and visual information over a 25-min delay
period (via the WMS-III Wordlists and VR subtests respectively). Scores
onVRcopyconditionwereusedtocontrolfordifferencesinvisuospatial
ability between participants and as a statistical covariate in the visual
memory data analyses.
4. Executive functioning, working memory, and attention (EFWMA). The
Delis and Kaplan Executive Function System (D-KEFS) Color-Word
Interference Test (18), color-naming, word-reading, inhibition, and in-
hibition-switching components were administered in series to obtain
measures of executive functioning. Completion times for inhibition and
inhibition switching were analyzed. To assess attention and working
memory, total correct responses on the WMS-III letter number sequenc-
ing (17) were analyzed.
5. Verbal fluency. Total correct responses on the D-KEFS verbal fluency
test (18) (letter fluency, category fluency, and category switching con-
ditions) and the percentage switching accuracy and errors made across
all three conditions were analyzed.
A priori composites were calculated for each construct by converting
raw scores for each participant on each test to age-adjusted scaled scores
according to established norms (17, 18) and averaging the scaled scores.
Composites reflecting broader constructs are more appropriate mea-
sures of cognitive ability and exhibit higher reliability than the indi-
vidual components represented by single neuropsychological tests (19).
These constructs were used as dependent variables in hierarchical linear
regression analyses to examine the FT by APOE 4 status interaction on
cognition.
Statistical analyses
Data were analyzed using the Statistical Package for Social Sci-
ences (version 11.5; SPSS Inc., Chicago, IL). Cohort characteristics
were explored via one-way ANOVA for continuous data and using
the Pearson method for 2  2 contingency tables (
2) for categorical
data. Homogeneity of variance and normality of data distributions
were evaluated for FT and neuropsychological data in the groups [4
carriers (4) vs. noncarriers (4)]. Analysis of covariance/multi-
variate analysis of covariance (MANCOVA) was conducted to com-
pare the effect of 4 status (absence vs. presence) on FT, measures of
mood, and cognitive performance, separately. Where appropriate,
age and/or VR total copy score served as statistical covariates. The
interaction between FT and 4 status on composites of cognitive
functioning was further examined via hierarchical linear regression
analyses. Main effects involving FT concentrations were subse-
quently explored via Pearson’s correlation coefficient (r).
Results
Characteristics of the cohort stratified by 4 status are
reported in Table 1. The 4 group was significantly older
thanthe4group[F(1, 43)5.75,P0.02].Thegroupswere
similar for years of education, estimated FSIQ, body mass
index, blood pressure, cigarette and alcohol use, current
medications, and medical history. SHBG was higher in the
4, compared with 4 group (44.4  16.4 vs. 34.5  14.0
nmol/liter,P0.04);however,FTwassimilarinbothgroups
(0.27  0.06 vs. 0.26  0.07 nmol/liter, respectively).
Evaluation of group differences
Analysis of covariance was performed using FT as the
dependent variable and 4 status as the independent vari-
able, with age as a statistical covariate. Age significantly
influenced FT [F(1, 42)  8.79, P  0.01]. After adjusting for
age, there was no significant effect of 4 status on FT [F(1, 42)
 2.95, P  0.09]. Unadjusted group means and sds for 4
and 4 groups for FT are presented in Table 1.
Mood
MANCOVA was performed to examine group differences
on anxious and depressed mood. After adjusting for age,
there was no significant effect of 4 status on depressed and
anxious mood (F(2, 41)  1.18, P  0.32). The statistical co-
variate age did not influence mood (F(2, 41)  0.08, P  0.92).
Cognitive performance
Separate MANCOVAs were performed using the individ-
ual measures of cognitive functioning as dependent vari-
ables, with age and VR total copy score as statistical covari-
ates where appropriate. The 4 and 4 groups performed
similarly on general cognition (CAMCOG-R total score), vi-
sual memory (WMS-III VR immediate and delayed recall,
percentage retention, and recognition indices), EFWMA
(WMS-III letter number sequencing total recall and D-KEFS
inhibition and inhibition-switching completion times), and
verbal fluency (D-KEFS verbal fluency test indices).
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performance. MANCOVA was performed using raw scores
on the WMS-III Wordlists immediate and delayed recall,
percentage retention, and recognition indices as dependent
variables.Agesignificantlyinfluencedthesedependentvari-
ables [F(4, 39)  3.42, P  0.02]. After adjusting for age, the
overall MANCOVA was significant with respect to the in-
fluence of 4 status [F(4, 39)  3.22, P  0.02] on these four mea-
sures of verbal memory. Because the overall MANCOVA
was significant, subsequent analysis of each individual de-
pendent variable showed significant differences in scores
between 4 and 4 groups, on delayed recall [F(1, 42) 
9.47, P  0.01] and percentage retention [F(1, 42)  8.31, P 
0.01] indices of the WMS-III Wordlists.
The interaction between 4 and FT on cognitive perfor-
mance in the cohort was explored via hierarchical linear
regression analyses, using FT, 4 status, and 4  FT as
predictors of the following: 1) CAMCOG-R total score; 2)
immediate memory; 3) delayed memory; 4) EFWMA; and 5)
verbal fluency constructs. Hierarchical linear regression
models are presented in Table 2. In line with the previous
MANCOVA analyses, 4 status was significantly related to
delayed memory performance. The 4  FT interaction was
significantly related to performance on the CAMCOG-R and
EFWMA. These 4  FT interactions were subsequently ex-
plored within 4 and 4 groups by calculating separately
the correlation coefficient (r).
The linear relationship between CAMCOG-R scores and
FT within the 4 and 4 groups is summarized in Fig. 1,
A and B, respectively. CAMCOG-R scores positively corre-
lated with FT (r  0.46, n  29, P  0.01) in the 4 group.
There was significant negative correlation between FT con-
centrations and EFWMA in the 4 group (r  0.58, n 
16, P  0.02), as shown in Fig. 1, C and D.
Discussion
We systematically investigated the interaction between 4
status and testosterone concentrations on cognition in ap-
parently healthy older men. No difference in FT between the
groups was noted in this cohort. Consistent with previous
findings (20), we observed that APOE 4 carriers had lower
TABLE 1. Characteristics of healthy older men stratified by APOE 4 status
Variable 4 (n  16) 4 (n  29) P value
Age (yr)
a 74.31  5.82 69.52  6.71 0.02
Education (yr)
a 13.31  4.11 11.41  3.27 0.10
NART estimated premorbid FSIQ
a 118.19  6.66 120.62  18.50 0.62
Body mass index (kg/m
2)
a 26.79  2.94 28.85  3.68 0.06
Medical history (%)
Diabetes 12.50 13.79 0.90
Cardiovascular risk factors
b 25.00 24.14 0.95
Hypertension 43.75 27.59 0.27
Current medication (%)
Antihypertensives 18.75 17.24 0.90
Anticoagulants 25.00 17.24 0.53
Nonsteroidal antiinflammatories 43.75 34.48 0.54
Sedatives/hypnotics 6.25 13.79 0.27
Lifestyle factors
Alcohol use (standard drinks/day)
a 1.22  1.21 1.63  1.11 0.26




Blood pressure (mm Hg)
a
Systolic 141.08  25.69 145.71  20.57 0.51
Diastolic 79.73  11.78 82.14  8.93 0.44
Biochemical assessments
Calculated free testosterone (nmol/liter)
a, c 0.27  0.06 0.26  0.07 0.09
NART, National Adult Reading Test.
a Mean  SD.
b Individuals with a history of heart disease, hypercholesterolemia, and statin use.
c Age-adjusted ANCOVA.
TABLE 2. Hierarchical linear regression models for composites of
cognitive constructs
Unstandardized  SE t P value
General cognition
4 status 0.69 1.60 0.43 0.67
FT 16.42 11.45 1.44 0.16
4xFT 65.16 23.96 2.72 0.01
Immediate memory
4 status 1.19 0.75 1.58 0.12
FT 3.76 5.40 0.70 0.49
4xFT 14.39 12.06 1.19 0.24
Delayed memory
4 status 1.54 0.65 2.38 0.02
FT 4.76 4.64 1.03 0.31
4xFT 8.88 10.46 0.85 0.40
EFWMA
4 status 0.55 0.72 0.76 0.45
FT 3.04 5.16 0.59 0.56
4xFT 32.57 10.58 3.08 0.01
Verbal fluency
4 status 0.56 0.54 1.03 0.31
FT 0.66 3.87 0.17 0.86
4xFT 11.49 8.62 1.33 0.19
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with non-4 carriers.
The novel finding is the interaction between FT and 4 status
on general cognition and EFWMA. In cognitively healthy older
men without the 4 allele, FT levels were positively correlated
with general cognitive ability (i.e. CAMCOG-R scores). By con-
trast, in men who possess the 4 allele, FT levels correlated
negatively with EFWMA. These statistically significant obser-
vations are of potential clinical relevance as testosterone sup-
plementation has been postulated to have beneficial effects on
cognition (5, 6); however, this was not addressed here. Because
higher testosterone concentrations were associated with lower
performance on EFWMA in 4 carriers, testosterone supple-
mentationmaynotbebeneficialinthisgroup(whoareathigher
relative risk for AD). It may be necessary to stratify men by 4
status when examining the relationship between testosterone
and cognition or when designing interventional trials of tes-
tosteronereplacementforthepreventionofcognitivedeclinein
older men.
Particular strengths of this study were the careful case
selection, allowance for potential confounders including
mood, detailed neuropsychological assessments, and the ex-
amination of a cohort free of cognitive impairment and de-
mentia. Additionally, composite measures of cognitive per-
formance were determined a priori and used to increase the
validity of our analysis. Limitations of this study are the
relatively small sample size, the cross-sectional nature, and
the need to adjust for age differences between the groups. A
larger study with follow-up to provide a longitudinal or
prospective component would be highly desirable to extend
our present findings.
Briefly, we observed an interaction between testosterone
and APOE 4 on cognition in healthy older men. In men not
possessing an 4 allele, higher testosterone concentrations
were associated with better general cognition. However,
higher testosterone concentrations in men who possessed an
4 allele had lower performance on executive functioning,
working memory, and attention tasks. APOE 4 status
should be taken into account when investigating the rela-
tionship between androgens and cognition in older men.
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